P
Protalix Biotherapeutics Inc
F:PBDA
Protalix Biotherapeutics Inc
F:PBDA
Price:
1.634
EUR
0.37%
Market Closed
Market Cap:
€119.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
A
|
Aleafia Health Inc
OTC:ALEAF
|
CA |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
Italgas SpA
MIL:IG
|
IT |
|
Central Omega Resources Tbk PT
IDX:DKFT
|
ID |
|
D
|
Draganfly Inc
NASDAQ:DPRO
|
CA |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
Basf Se
LSE:0BFA
|
DE |
Wall St Price Targets
PBDA Price Targets Summary
Protalix Biotherapeutics Inc
Protalix Biotherapeutics Inc
Wall Street analysts forecast PBDA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PBDA is 10.111 EUR with a low forecast of 9.102 EUR and a high forecast of 11.354 EUR.
Lowest Forecast
Price Target
9.102
EUR
457% Upside
Average Forecast
Price Target
10.111
EUR
519% Upside
Highest Forecast
Price Target
11.354
EUR
595% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBDA's stock price target?
Price Target
10.111
EUR
10.111
EUR
According to Wall Street analysts, the average 1-year price target for PBDA is 10.111 EUR with a low forecast of 9.102 EUR and a high forecast of 11.354 EUR.
What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
15%
15%
Over the last 14 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 2 years is 15%.
